Loading…
DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 10:45 - 11:45
#S0801: The Impact of Innovation and Novel Pathways: The Role of the Regulator

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

The International Coalition of Medicines Regulatory Authorities (ICMRA) will explore role of regulators in the current international landscape, including the impact of innovation and novel pathways. The session will be delivered by members of ICMRA who represent a number of leading regulators across Europe and beyond.

Chair

Ian Hudson

Speaker

Horizon Scanning: Methodologies and Best Practice
Tatsuya Kondo, MD, PhD

Leveraging Outcomes of Horizon Scanning
Agnès Saint-Raymond, MD

Novel Approaches to Licensing
John Patrick Stewart, MD

Overview of Projects
Lorraine Nolan, PhD



Speakers
avatar for Ian Hudson

Ian Hudson

Chief Executive, Medicines and Healthcare products Regulatory Agency (MHRA)
Dr Ian Hudson became Chief Executive of the MHRA in September 2013. He is a physician who practiced as a paediatrician prior to working in the pharmaceutical industry in clinical research and development. In 2001 he joined the former Medicines Control Agency as its Licencing Division... Read More →
avatar for Tatsuya Kondo

Tatsuya Kondo

Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
Dr. Tatsuya Kondo is Chief Executive of PMDA since 2008. He spent most of his career as a neurosurgeon after his graduation from the University of Tokyo in 1968. He has various experiences including a hospital doctor, a fellowship in Max-Planck Institute for brain tumor research... Read More →
avatar for Lorraine Nolan

Lorraine Nolan

Chief Executive, Health Products Regulatory Authority (HPRA)
Ms Nolan joined the HPRA in 2001 and since that time has held a number of different roles at senior level within the organisation across a range of areas including inspection and authorisation of human medicines, medical devices, cosmetics and controlled substances. Prior to assuming... Read More →
avatar for Agnès Saint-Raymond

Agnès Saint-Raymond

Head of Division International Affairs, European Medicines Agency
Agnes is an MD and qualified French Paediatrician. She worked as a paediatrician in a paediatric Hospital in Paris, France, then in pharmaceutical industry, and then moved to the French Medicines Agency. In 2000 she joined the European Medicines Agency (EMA) and was responsible for... Read More →
avatar for John Stewart

John Stewart

Director General, Health Canada
The Director General of the Therapeutic Products Directorate in the Health Products and Food Branch of Health Canada; overseeing the review and approval of drug and medical devices submissions seeking authorization to be sold on the Canadian market or in the context of clinical trials... Read More →


Wednesday February 6, 2019 10:45 - 11:45 CET
K2 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  08 Regional Updates, Session
  • Featured Topics Regulatory Science
  • Tags Session